Neogen (NASDAQ: NEOG) net income
Neogen reported a net loss of $7.9m for fiscal 2026; in fiscal 2025 it reported a net loss of $1,092m. Earnings per share were −$0.04.
Neogen's best year of the last 10 was fiscal 2018. The biggest drop was in fiscal 2022, −20.7%. It reported a loss in 4 of those 10 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2026 | −$7.9m | — | −0.9% | −$0.04 |
| 2025 | −$1,092m | — | −122.1% | −$5.03 |
| 2024 | −$9.4m | — | −1.0% | −$0.04 |
| 2023 | −$22.9m | −147.3% | −2.8% | −$0.12 |
| 2022 | $48.3m | −20.7% | 9.2% | $0.45 |
| 2021 | $60.9m | +2.4% | 13.0% | $0.57 |
| 2020 | $59.5m | −1.2% | 14.2% | $1.13 |
| 2019 | $60.2m | −4.7% | 14.5% | $1.16 |
| 2018 | $63.1m | +44.2% | 15.9% | $1.23 |
| 2017 | $43.8m | — | 12.2% | $1.16 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Neogen net income compared with its sector
By net income for its latest fiscal year, Neogen ranks 187th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Neogen, −0.9%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 185th | Protalix Biotherapeutics | −$6.6m | −12.5% |
| 186th | Stoke Therapeutics | −$6.9m | −3.7% |
| 187th | Neogen | −$7.9m | −0.9% |
| 188th | Bruker | −$8.6m | −0.3% |
| 189th | Cronos Group | −$9.4m | −4.9% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Neogen
- How much did Neogen earn in fiscal 2026?
- Neogen reported a net loss of $7.9m for fiscal 2026. In fiscal 2025 it reported a net loss of $1,092m.
- What are the earnings per share of Neogen?
- They were −$0.04 in fiscal 2026, compared with −$5.03 in fiscal 2025.
- What was the most profitable year for Neogen?
- Of its last 10 fiscal years, fiscal 2018, with $63.1m.
- Where does Neogen rank in its sector by net income?
- It ranks 187th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Neogen come from?
- From the annual report (Form 10-K) that Neogen files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Neogen files with the SEC. The filing for each fiscal year: 2026 · 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017. More on Neogen: the Neogen page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.